Cargando…

Lubiprostone stimulates small intestinal mucin release

BACKGROUND: Lubiprostone is a synthetic bicyclic fatty acid derivative of prostaglandin E1 (PGE(1)) used for chronic constipation. The best known action of lubiprostone is simulation of Cl(-) dependent fluid secretion. In a mouse model of the genetic disease cystic fibrosis, we previously showed tha...

Descripción completa

Detalles Bibliográficos
Autor principal:	De Lisle, Robert C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523065/ https://www.ncbi.nlm.nih.gov/pubmed/23130661 http://dx.doi.org/10.1186/1471-230X-12-156

Ejemplares similares

Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
por: De Lisle, Robert C, et al.
Publicado: (2010)

Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
por: Mizumori, Misa, et al.
Publicado: (2009)

Stimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication
por: Majewski, Marek, et al.
Publicado: (2014)

Role of Lubiprostone on Gastrointestinal Motility
por: Jun, Jae Yeoul
Publicado: (2013)

Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation
por: Rao, Satish S.C., et al.
Publicado: (2021)

Clubbed Digits Presumably Caused by Lubiprostone
por: Kawamoto, Ryuichi, et al.
Publicado: (2021)

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation
por: Pennington, Becky, et al.
Publicado: (2018)

Lubiprostone: a novel treatment for chronic constipation
por: Lacy, Brian E, et al.
Publicado: (2008)

Effectiveness and safety of lubiprostone after switching from stimulant laxatives in elderly patients with chronic constipation
por: Maruyama, Masaki, et al.
Publicado: (2023)

Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP(1))-mediated Pathway
por: Chan, Walter W, et al.
Publicado: (2013)

Methadone but not Morphine Inhibits Lubiprostone-Stimulated Cl(−) Currents in T84 Intestinal Cells and Recombinant Human ClC-2, but not CFTR Cl(−) Currents
por: Cuppoletti, John, et al.
Publicado: (2012)

Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice
por: Arakawa, Kentaro, et al.
Publicado: (2019)

Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders
por: Cryer, Byron, et al.
Publicado: (2017)

Factors associated with long-term efficacy of lubiprostone for chronic constipation
por: Morise, Takashi, et al.
Publicado: (2023)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
por: Soubra, Mahmoud, et al.
Publicado: (2012)

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly
por: Gras-Miralles, Beatriz, et al.
Publicado: (2013)

Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series
por: Torrico, Tyler J, et al.
Publicado: (2022)

Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation
por: Adams, Atoya, et al.
Publicado: (2021)

Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers
por: Kato, Takayuki, et al.
Publicado: (2017)

Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial
por: Hussain, Sunny Z., et al.
Publicado: (2021)

Short Chain Fatty Acids Effect on Chloride Channel ClC-2 as a Possible Mechanism for Lubiprostone Intestinal Action
por: Catalán, Marcelo A., et al.
Publicado: (2020)

Possible Effect of Concomitant Prokinetics and Herbal Medicines against Nausea in Patients Taking Lubiprostone
por: Yamamoto, Takatsugu, et al.
Publicado: (2017)

Effects of Lubiprostone on Pacemaker Activity of Interstitial Cells of Cajal from the Mouse Colon
por: Jiao, Han-Yi, et al.
Publicado: (2014)

Study of mucin turnover in the small intestine by in vivo labeling
por: Schneider, Hannah, et al.
Publicado: (2018)

The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn’s Disease but Not Ulcerative Colitis Patients
por: Park, Young Su, et al.
Publicado: (2023)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020)

A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
por: Cryer, Byron, et al.
Publicado: (2014)

Lubiprostone improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled 2-way crossover study
por: Matsuura, Mizue, et al.
Publicado: (2017)

Breakdown of Mucin as Barrier to Digestive Enzymes in the Ischemic Rat Small Intestine
por: Chang, Marisol, et al.
Publicado: (2012)

Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR
por: Akita, Hiraku, et al.
Publicado: (2020)

A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa
por: Kang, Sang Bum, et al.
Publicado: (2015)

Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
por: Lunsford, Tisha N, et al.
Publicado: (2010)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

A meta-analysis of randomized controlled trials of the addition of lubiprostone to bowel preparation before colonoscopy
por: Li, Peng, et al.
Publicado: (2020)

Lubiprostone Decreases the Small Bowel Transit Time by Capsule Endoscopy: An Exploratory, Randomised, Double-Blind, Placebo-Controlled 3-Way Crossover Study
por: Matsuura, Mizue, et al.
Publicado: (2014)

Intestinal Antigenicity of Ovarian Mucinous Cystadenomas
por: Nairn, R. C., et al.
Publicado: (1971)

Mucin Dynamics in Intestinal Bacterial Infection
por: Lindén, Sara K., et al.
Publicado: (2008)

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes
por: Hayat, Maham, et al.
Publicado: (2019)

Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors
por: Cuppoletti, John, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kbhqksmiv81c9o3k2u0k3qqetv